Evidence map›Paper›PMID 24760886›Full record

ArticleJournal of virology2014

Involvement of hepatitis C virus NS5A hyperphosphorylation mediated by casein kinase I-α in infectious virus production.

Takahiro Masaki, Satoko Matsunaga, Hirotaka Takahashi, Kenji Nakashima, Yayoi Kimura, Masahiko Ito, Mami Matsuda, Asako Murayama, Takanobu Kato, Hisashi Hirano and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Hepatitis C Virus Replication.Cold Spring Harbor perspectives in medicine · 2020
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Takahiro MasakiDepartment of Virology II, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo, Japan Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Satoko MatsunagaProteo-Science Center, Ehime University, Matsuyama, Ehime, Japan.
Hirotaka TakahashiProteo-Science Center, Ehime University, Matsuyama, Ehime, Japan.
Kenji NakashimaDepartment of Infectious Diseases, Hamamatsu University School of Medicine, Handayama, Higashi-ku, Hamamatsu, Japan.
Yayoi KimuraGraduate School of Medical Life Science and Advanced Medical Research Center, Yokohama City University, Fukuura, Kanazawa-ku, Yokohama, Japan.
Masahiko ItoDepartment of Infectious Diseases, Hamamatsu University School of Medicine, Handayama, Higashi-ku, Hamamatsu, Japan.
Mami MatsudaDepartment of Virology II, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo, Japan.
Asako MurayamaDepartment of Virology II, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo, Japan.
Takanobu KatoDepartment of Virology II, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo, Japan.
Hisashi HiranoGraduate School of Medical Life Science and Advanced Medical Research Center, Yokohama City University, Fukuura, Kanazawa-ku, Yokohama, Japan.
Yaeta EndoProteo-Science Center, Ehime University, Matsuyama, Ehime, Japan.
Stanley M LemonLineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA Division of Infectious Diseases, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Takaji WakitaDepartment of Virology II, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo, Japan.
Tatsuya SawasakiProteo-Science Center, Ehime University, Matsuyama, Ehime, Japan.
Tetsuro SuzukiDepartment of Infectious Diseases, Hamamatsu University School of Medicine, Handayama, Higashi-ku, Hamamatsu, Japan tesuzuki@hama-med.ac.jp.
National Institute of Infectious Diseases · JPEhime University · JPHamamatsu University School of Medicine · JPYokohama City University · JPUniversity of North Carolina at Chapel Hill · US

Funding

Micro-RNA 122 and Chronic Hepatitis CR01AI095690 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LEMON, STANLEY M. · 2011 to 2020
$3.7M
NIAID NIH HHS R01 AI095690NIAID NIH HHS R01-AI095690
6 · The paper itself

Abstract

unlabelledNonstructural protein 5A (NS5A) of hepatitis C virus (HCV) possesses multiple functions in the viral life cycle. NS5A is a phosphoprotein that exists in hyperphosphorylated and basally phosphorylated forms. Although the phosphorylation status of NS5A is considered to have a significant impact on its function, the mechanistic details regulating NS5A phosphorylation, as well as its exact roles in the HCV life cycle, are still poorly understood. In this study, we screened 404 human protein kinases via in vitro binding and phosphorylation assays, followed by RNA interference-mediated gene silencing in an HCV cell culture system. Casein kinase I-α (CKI-α) was identified as an NS5A-associated kinase involved in NS5A hyperphosphorylation and infectious virus production. Subcellular fractionation and immunofluorescence confocal microscopy analyses showed that CKI-α-mediated hyperphosphorylation of NS5A contributes to the recruitment of NS5A to low-density membrane structures around lipid droplets (LDs) and facilitates its interaction with core protein and the viral assembly. Phospho-proteomic analysis of NS5A with or without CKI-α depletion identified peptide fragments that corresponded to the region located within the low-complexity sequence I, which is important for CKI-α-mediated NS5A hyperphosphorylation. This region contains eight serine residues that are highly conserved among HCV isolates, and subsequent mutagenesis analysis demonstrated that serine residues at amino acids 225 and 232 in NS5A (genotype 2a) may be involved in NS5A hyperphosphorylation and hyperphosphorylation-dependent regulation of virion production. These findings provide insight concerning the functional role of NS5A phosphorylation as a regulatory switch that modulates its multiple functions in the HCV life cycle. IMPORTANCE: Mechanisms regulating NS5A phosphorylation and its exact function in the HCV life cycle have not been clearly defined. By using a high-throughput screening system targeting host protein kinases, we identified CKI-α as an NS5A-associated kinase involved in NS5A hyperphosphorylation and the production of infectious virus. Our results suggest that the impact of CKI-α in the HCV life cycle is more profound on virion assembly than viral replication via mediation of NS5A hyperphosphorylation. CKI-α-dependent hyperphosphorylation of NS5A plays a role in recruiting NS5A to low-density membrane structures around LDs and facilitating its interaction with the core for new virus particle formation. By using proteomic approach, we identified the region within the low-complexity sequence I of NS5A that is involved in NS5A hyperphosphorylation and hyperphosphorylation-dependent regulation of infectious virus production. These findings will provide novel mechanistic insights into the roles of NS5A-associated kinases and NS5A phosphorylation in the HCV life cycle.

Indexed as

Amino Acid SequenceBlotting, WesternCasein Kinase IalphaCells, CulturedFluorescent Antibody TechniqueHepacivirusHepatitis CHumansImmunoprecipitationMolecular Sequence DataPhosphorylationReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionRNA-Dependent RNA PolymeraseRNA, MessengerRNA, Small InterferingCasein Kinase IalphaNS-5 protein, hepatitis C virusRNA-Dependent RNA PolymeraseRNA, MessengerRNA, Small InterferingViral Nonstructural Proteins

Identifiers

PMID24760886
PMCPMC4054430
OpenAlexW2158642793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.